
C. Light Technologies
Founded Year
2014Stage
Seed | AliveTotal Raised
$3.96MLast Raised
$500K | 2 yrs agoAbout C. Light Technologies
C. Light operates as a neuro-technology and artificial intelligence (AI) company. The company aims to use artificial intelligence and machine learning techniques to assess changes in eye movement as subtle as one-hundredth the size of a human hair with the help of a new tracking scanning laser ophthalmoscope device. It was founded in 2014 and is based in Medford, Massachusetts.
ESPs containing C. Light Technologies
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The AI-assisted endoscopy market aims to improve the accuracy and standardization of endoscopic procedures through the use of artificial intelligence. This technology can potentially assist gastroenterologists in identifying precancerous lesions, detecting missed adenomas, and classifying and detecting early gastric cancers. Additionally, AI-driven algorithms and computer vision advances can accel…
C. Light Technologies named as Challenger among 7 other companies, including Proscia, PathAI, and Iterative Health.
Expert Collections containing C. Light Technologies
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
C. Light Technologies is included in 2 Expert Collections, including Artificial Intelligence.
Artificial Intelligence
10,944 items
Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.
Digital Health
10,563 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
C. Light Technologies Patents
C. Light Technologies has filed 3 patents.
The 3 most popular patent topics include:
- Blood tests
- Cognitive science
- Eye procedures

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
12/14/2017 | 12/14/2021 | Vision, Neurotrauma, Ophthalmology, Neurological disorders, Visual system | Grant |
Application Date | 12/14/2017 |
---|---|
Grant Date | 12/14/2021 |
Title | |
Related Topics | Vision, Neurotrauma, Ophthalmology, Neurological disorders, Visual system |
Status | Grant |
Latest C. Light Technologies News
May 12, 2023
FDA gives green light to C.Light eye monitor C.Light’s Retitrack will be able to provide physicians with insights into oculomotor function. C.Light’s device records and analyses temporal characteristics of fixational and saccadic eye motion down . C. Light Technologies has received 510(k) clearance from U.S. Food and Drug Administration (FDA) for its retinal eye device Retitrack. According to the Massachusetts, US-based healthtech startup is the first retinal eye-movement monitor to be cleared for use in healthcare for non-invasive clinical assessments . The device is a tabletop eye movement monitor that records 10-second, high-resolution, and non-invasive retinal video scans at the photoreceptor level. Using accompanying software, it analyses temporal characteristics of fixational and saccadic eye motion down to 0.1 degrees. Fixation movements such as microsaccades and drift can be extracted by the software to generate a real-time report for healthcare practitioners. Recommended Reports Retitrack device. Image credit: C.Light Technologies It is intended for use by healthcare practitioners and will facilitate further clinical insights into a patient’s oculomotor function. Current technology only reports on retinal structure, according to C.Light CEO and co-founder Dr Christy Sheehy-Bensinger. Oculomotor function is an important clinical test. Abnormalities of eye movements may indicate vision impairment and are sometimes symptoms for other conditions. Research has previously been conducted in using technology to diagnose autism spectrum disorder (ASD) in children based on visual gaze. “Fixational eye movements have previously eluded clinical quantification, posing a significant challenge to healthcare professionals who are aiming to improve prognostic care. With our novel technology, we’ve unlocked the potential of one of the smallest motor movements in the human body, offering invaluable data that will drive the future of clinical care,” said Dr Sheehy-Bensinger. C. Light has raised more than $8m with funding from Yamaha Motor Ventures and Creative Ventures. The company has also been awarded grants from the National Institute of Health and the Alzheimer’s Drug Discovery Foundation. Share this article
C. Light Technologies Frequently Asked Questions (FAQ)
When was C. Light Technologies founded?
C. Light Technologies was founded in 2014.
Where is C. Light Technologies's headquarters?
C. Light Technologies's headquarters is located at 84 High Street, Medford.
What is C. Light Technologies's latest funding round?
C. Light Technologies's latest funding round is Seed.
How much did C. Light Technologies raise?
C. Light Technologies raised a total of $3.96M.
Who are the investors of C. Light Technologies?
Investors of C. Light Technologies include Alzheimer's Drug Discovery Foundation, National Institutes of Health, Yamaha Motor Ventures, Creative Ventures, Berkeley SkyDeck and 10 more.
Who are C. Light Technologies's competitors?
Competitors of C. Light Technologies include NeuraLight.
Compare C. Light Technologies to Competitors
Innodem Neuroscience is the maker of Pigio, an app that uses AI-powered mobile software technology to allow paralyzed or intubated patients to communicate with eye movements. Users will be able to control a cursor on the screen with their eye movements and select pre-defined sentences and words displayed on the screen, which will then produce an audio output.

Neurotrack offers a digital medicine solution for Alzheimer's disease. It develops cognitive screening tools to help healthcare providers and individuals assess and monitor diseases. It streamlines workflows, identifies impairment early, and provides new pharmaceutical treatment options. The company was founded in 2012 and is based in Redwood City, California.

RightEye is a health technology company using eye tracking for patient care. RightEye leverages scientific research and a patented, cloud-based software platform to deliver eye movement tests and therapies. RightEye's eye tracking platform allows for early and accurate detection of issues, including concussions, traumatic brain injuries, autism, reading, general eye health, performance vision, and Parkinson's disease, and other movement disorders.

NeuraLight delivers artificial intelligence (AI)- driven neurology software designed to help patients affected by neurological disorders. The company transforms clinical development, diagnostics, and precision medicine in neurology with artificial intelligence (AI) to accelerate drug development, patient monitoring, and precision care for patients with neurological disorders using oculometric data captured with a standard webcam or smartphone. The company was founded in 2021 and is based in Tel Aviv, Israel.